Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALPI | P09923 | 1/20 | 0.38 |
| ▸ | ALPG | P10696 | 1/20 | 0.38 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maltitol SCHEMBL5146157 | 0.99 | PPARG (0.39) | PPARGPPARDPPARAL3MBTL1MEN1 | |
| Lactitol SCHEMBL15528125 | 0.98 | PPARG (0.40) | PPARGPPARDPPARAL3MBTL1MEN1 | |
| Maltitol SCHEMBL2722358 | 0.98 | PPARG (0.40) | PPARGPPARDPPARAL3MBTL1MEN1 | |
| Maltitol SCHEMBL10536052 | 0.98 | PPARG (0.40) | PPARGPPARDPPARAL3MBTL1MEN1 | |
| Lactitol SCHEMBL915752 | 0.98 | PPARG (0.40) | PPARGPPARDPPARAL3MBTL1MEN1 | |
| Maltitol SCHEMBL2452278 | 0.98 | PPARG (0.40) | PPARGPPARDPPARAL3MBTL1MEN1 | |
| Lactitol SCHEMBL15621059 | 0.97 | PPARG (0.39) | PPARGPPARDPPARAL3MBTL1MEN1 | |
| Lactitol SCHEMBL6536267 | 0.97 | PPARG (0.39) | PPARGPPARDPPARAL3MBTL1MEN1 | |
| Maltitol SCHEMBL14966604 | 0.97 | PPARG (0.39) | PPARGPPARDPPARAL3MBTL1MEN1 | |
| Maltitol SCHEMBL8094264 | 0.97 | L3MBTL1 (0.41) | PPARGPPARDPPARAL3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040057993-A1 | Rapidly disintegrating solid oral dosage form | ELAN PHARMA INTERNATIONAL LIMITED | 2004-03-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040057993-A1 | Rapidly disintegrating solid oral dosage form | SI, PGA5, SORD | PPARG 3563/4885PPARD 2464/4885PPARA 3176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.